| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2008 | EP1883406A2 Compositions and methods for the sustained release of beta-alanine |
| 02/06/2008 | EP1883405A2 Methods for treating nephrolithiasis |
| 02/06/2008 | EP1883404A1 P38 inhibitors and methods of use thereof |
| 02/06/2008 | EP1883403A2 Keratinocyte growth factor receptor - tyrosine specific inhibitors for the prevention of cancer metastatis |
| 02/06/2008 | EP1883402A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 02/06/2008 | EP1883401A1 Anti-microbial agent |
| 02/06/2008 | EP1883397A2 Dispersible bosertan tablet |
| 02/06/2008 | EP1883393A2 Stabilized oral pharmaceutical compositions of cephalosporins |
| 02/06/2008 | EP1883390A2 Topical compositions |
| 02/06/2008 | EP1883302A2 Jak kinase inhibitors and their uses |
| 02/06/2008 | EP1883298A1 Glufosfamide combination therapy |
| 02/06/2008 | EP1845981A4 Synthesis of sodium narcistatin and related compounds |
| 02/06/2008 | EP1682076A4 Inhibitors of coronavirus protease and methods of use thereof |
| 02/06/2008 | EP1392282B1 Dermatological and cosmetic compositions comprising a furfuryl derivative |
| 02/06/2008 | EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists |
| 02/06/2008 | EP1324980B1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/06/2008 | CN101120099A Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna |
| 02/06/2008 | CN101120086A Flavivirus replicon constructs for tumour therapy |
| 02/06/2008 | CN101120011A Macrolides |
| 02/06/2008 | CN101120006A Proteasome inhibitors and methods of using the same |
| 02/06/2008 | CN101120005A Thiazolopyrimidine compounds for the modulation of chemokine receptor activity |
| 02/06/2008 | CN101120004A 8a,9-dihydro-4ah-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 02/06/2008 | CN101120003A Thieno-pyridine derivatives as GABA-B allosteric enhancers |
| 02/06/2008 | CN101120002A Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 02/06/2008 | CN101120001A 12位取代姆替林衍生物 12 to replace Tim triptyline derivatives |
| 02/06/2008 | CN101119998A Pyrazolo [1,5-a] pyrimidine adenosine a2a receptor antagonists |
| 02/06/2008 | CN101119996A Chemical compouns |
| 02/06/2008 | CN101119995A Non steroidal glucocorticoid receptor modulators |
| 02/06/2008 | CN101119994A Nicotinic acetycholine receptor ligands |
| 02/06/2008 | CN101119993A Aminophenyl derivatives as selective androgen receptor modulators |
| 02/06/2008 | CN101119992A Tricyclic delta-opioid modulators |
| 02/06/2008 | CN101119991A Salt of proline derivative, solvate thereof, and production method thereof |
| 02/06/2008 | CN101119990A (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 02/06/2008 | CN101119989A Chroman derivatives and uses thereof |
| 02/06/2008 | CN101119988A Chemical compouns |
| 02/06/2008 | CN101119987A Novel compounds |
| 02/06/2008 | CN101119986A Optically active tetrahydronaphthalene derivative |
| 02/06/2008 | CN101119985A N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application |
| 02/06/2008 | CN101119983A Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/06/2008 | CN101119982A Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/06/2008 | CN101119981A New benzothiazolesulfonamides |
| 02/06/2008 | CN101119980A New benzothiazolecarboxamides |
| 02/06/2008 | CN101119978A HSP90-inhibiting triazole derivatives |
| 02/06/2008 | CN101119976A HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
| 02/06/2008 | CN101119974A Amide derivatives as PPAR activators |
| 02/06/2008 | CN101119973A 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 02/06/2008 | CN101119971A Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same |
| 02/06/2008 | CN101119969A Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/06/2008 | CN101119964A 9-经取代四环素 9- substituted tetracycline |
| 02/06/2008 | CN101119963A Methamphetamine derivatives and conjugates for immunoassay |
| 02/06/2008 | CN101119951A Modulator |
| 02/06/2008 | CN101119758A Device for treatment of disorders in the oral cavity with nitric oxide, and manufacturing process for the same |
| 02/06/2008 | CN101119748A Pharmaceutical composition for treatment of diabetes |
| 02/06/2008 | CN101119747A Tissue factor production inhibitor |
| 02/06/2008 | CN101119742A Pharmaceutical composition for the prevention and treatment of cancer |
| 02/06/2008 | CN101119739A Methods for use of oral care compositions containing free-b-ring flavonoid anti-oxidants |
| 02/06/2008 | CN101119736A Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia |
| 02/06/2008 | CN101119735A Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells |
| 02/06/2008 | CN101119734A Rnai modulation of rsv and therapeutic uses thereof |
| 02/06/2008 | CN101119733A Method for reducing or avoiding adverse effect of steroid compound |
| 02/06/2008 | CN101119732A Contraceptive pharmaceutical preparation |
| 02/06/2008 | CN101119731A Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
| 02/06/2008 | CN101119730A Ointment |
| 02/06/2008 | CN101119729A Use of sodium channel blockers and their analogues for the treatment of nicotine dependency |
| 02/06/2008 | CN101119728A Indolomorphinan derivative having carboxy in 6'-position |
| 02/06/2008 | CN101119727A Use of cannabinoid receptor antagonists for the preparation of drugs in the treatment and prevention of type-2 diabetes |
| 02/06/2008 | CN101119726A Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 02/06/2008 | CN101119725A Solid forms of a chemokine receptor antagonist and methods of use thereof |
| 02/06/2008 | CN101119724A Substituted pyrazoles as modulators of chemokine receptors |
| 02/06/2008 | CN101119723A Thiazolium compounds and uses thereof |
| 02/06/2008 | CN101119722A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| 02/06/2008 | CN101119721A Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis |
| 02/06/2008 | CN101119720A Compositions containing polysaccharides |
| 02/06/2008 | CN101119718A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 02/06/2008 | CN101119717A Substituted phenols as active agents inhibiting vegf production |
| 02/06/2008 | CN101119716A External plaster containing flurbiprofen |
| 02/06/2008 | CN101119715A SPM 927 for add-on therapy of schizophrenia |
| 02/06/2008 | CN101119714A Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substitued by amino and phenyl groups |
| 02/06/2008 | CN101119713A Capsaicinoid gel formulation and uses thereof |
| 02/06/2008 | CN101119709A Orally bioavailable cci-779 formulations |
| 02/06/2008 | CN101119708A Bendamustine pharmaceutical compositions |
| 02/06/2008 | CN101119706A Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 02/06/2008 | CN101119705A Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPF-inhibitor for the treatment of central nervous system-related conditions |
| 02/06/2008 | CN101119648A Mixtures of fatty acid glycerides from C1 to C22 to improve zootechnical performances and/or the health of the intestine of animals |
| 02/06/2008 | CN101119634A Methods for promoting oral health in animals |
| 02/06/2008 | CN101117644A Diagnostics and therapeutics for glaucoma |
| 02/06/2008 | CN101117385A New polysiloxanes with quaternary ammonium groups, method for their manufacture and their use in cleaning and treating formulations |
| 02/06/2008 | CN101117354A Esterified pine pollen polysaccharide and preparation method and use thereof |
| 02/06/2008 | CN101117349A A macrocyclic oxidation substituted pentacyclic triterpanoids derivative and preparation method and use thereof |
| 02/06/2008 | CN101117348A A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof |
| 02/06/2008 | CN101117340A Ruthenium-anthraquinone conjugates, preparation method thereof and application for optical power therapeutic photosensitizer |
| 02/06/2008 | CN101117336A 7-(4-oxime-3-amino-1-piperidine) quinoline carboxylic acid derivative and method for making same |
| 02/06/2008 | CN101117335A Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 02/06/2008 | CN101117330A Tartrate of isofagomine and use thereof |
| 02/06/2008 | CN101117328A Fatty acid synthetase inhibitor and application for treating bacterial infection |
| 02/06/2008 | CN101117316A Oral liquid for preventing and remitting diabetes |
| 02/06/2008 | CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |